MedWatch

Novo breathes life into Alzheimer's speculations after executive hunt

As the market awaits clarification on whether Novo Nordisk will move into the market for Alzheimer's treatments, the pharmaceutical firm embarks on a hunt for an executive position with this disease as one of its focus areas.

Photo: Novo Nordisk / PR

Novo Nordisk now breathes life into the question of whether the Danish pharmaceutical firm is serious about officially starting the hunt for the gigantic market for pharmaceutical drugs against the dreaded brain disease Alzheimer's.

In a job posting appearing on, for example, LinkedIn, Novo Nordisk is actively searching for a new Vice President.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Related articles